Prognosis after acute coronary syndrome in relation with ventricular-arterial coupling and left ventricular strain

Agata Milewska1, Andrzej Minczykowski1, Tomasz Krauze1

  • 1Department of Cardiology-Intensive Therapy, Poznan University School of Medicine, Poznan, Poland.

Insights

Non-invasive measures of left ventricle (LV) and arterial function, including ventricular-arterial (VA) coupling, predict adverse outcomes in acute coronary syndrome (ACS) patients. These findings hold true independently of LV ejection fraction, offering valuable prognostic insights.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Clinical Prognostics

Background:

  • Prognostic value of non-invasive LV and arterial function indices in acute coronary syndrome (ACS) is not well-established.
  • Contemporary ACS treatments necessitate updated prognostic markers.
  • Ventricular-arterial (VA) coupling, LV global longitudinal peak systolic strain (GLPSS), global strain rate (GSR), and end-diastolic volume at end-diastolic pressure 30mmHg (V30) are key indices.

Purpose of the Study:

  • To assess the association of VA coupling, GLPSS, GSR, and V30 with long-term clinical outcomes in ACS patients.
  • To determine if these indices predict adverse events independently of traditional markers like LV ejection fraction.

Main Methods:

  • Echocardiography utilized in 569 ACS patients with >12 months follow-up.
  • Univariate Cox regression models analyzed associations, adjusting for clinical factors including reduced LV ejection fraction (<40%).
  • Combined endpoint: stroke, myocardial infarction, or death.

Main Results:

  • 57 clinical outcomes observed over a median 625-day follow-up.
  • Increased VA coupling (>1.68), V30 (>107mL), GLPSS (>-12.8%), and GSR (>-0.96 1/s) were robustly associated with increased hazard.
  • Hazard ratios ranged from 2.4 to 4.5 for these adverse predictors.

Conclusions:

  • Abnormal non-invasive LV and arterial function indices predict adverse outcomes in contemporary ACS patients.
  • These predictive capabilities are independent of LV ejection fraction.
  • These indices offer valuable prognostic information for ACS management.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
384
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
637
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
405
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
894
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
627